units

faculty-pg-pha

Faculty of Pharmacy and Pharmaceutical Sciences

Monash University

Monash University Handbook 2014 Postgraduate - Units

This unit entry is for students who completed this unit in 2014 only. For students planning to study the unit, please refer to the unit indexes in the the current edition of the Handbook. If you have any queries contact the managing faculty for your course or area of study.

print version


6 points, SCA Band 2, 0.125 EFTSL

Refer to the specific census and withdrawal dates for the semester(s) in which this unit is offered, or view unit timetables.

LevelPostgraduate
FacultyFaculty of Pharmacy and Pharmaceutical Sciences
OfferedAustralia (Other) First semester 2014 (Off-campus)
Australia (Other) Second semester 2014 (Off-campus)
Australia (Other) Summer semester A 2014 (Off-campus)
Coordinator(s)Professor Peter Stewart

Synopsis

This is an administrative unit code. Students cannot enrol in this unit.

Chief examiner(s)

Additional information on this unit is available from the faculty at:


6 points, SCA Band 2, 0.125 EFTSL

Refer to the specific census and withdrawal dates for the semester(s) in which this unit is offered, or view unit timetables.

LevelPostgraduate
FacultyFaculty of Pharmacy and Pharmaceutical Sciences
OfferedAustralia (Other) First semester 2014 (Off-campus)
Australia (Other) Second semester 2014 (Off-campus)
Australia (Other) Summer semester A 2014 (Off-campus)
Coordinator(s)Professor Peter Stewart

Synopsis

This is an administrative unit; students cannot enrol in this unit.

Chief examiner(s)

Additional information on this unit is available from the faculty at:


6 points, SCA Band 2, 0.125 EFTSL

Refer to the specific census and withdrawal dates for the semester(s) in which this unit is offered, or view unit timetables.

LevelPostgraduate
FacultyFaculty of Pharmacy and Pharmaceutical Sciences
OfferedParkville First semester 2014 (Off-campus)
Parkville Second semester 2014 (Off-campus)
Coordinator(s)Ms Kirstie Galbraith

Notes

For postgraduate coursework pharmacy discontinuation dates, please see http://www.pharm.monash.edu.au/students/pg-coursework/unit-discontinuation-dates.html

Quota applies

This unit is quota restricted. Selection is on a first-in, first enrolled basis. For more information please contact the faculty at http://monash.edu/pharm/future/contact/

Synopsis

This unit will provide students with theoretical information on evidence-based practice as well as the skills to incorporate evidence-based medicine into their clinical practice. Topics will include: formulation of clinical questions, searching the literature for best evidence, evaluating the evidence, and applying the evidence in patient care
Prescribed text
Guyatt G, Rennie D, eds. Users' Guides to the Medical Literature. Essentials of evidence-based clinical practice (2nd Edition) McGraw-Hill Professional, 2008.

Outcomes

At completion of this unit it is expected that students will be able to:

  • Formulate and answer clinical questions.
  • Evaluate the literature for validity and clinical utility.
  • Use electronic and paper based resources to assist in patient care.
  • Search relevant databases for current best evidence.
  • Appreciate the role of guidelines and decision support software in guiding therapy.

Assessment

Development and submission of your clinical question: 10%
Literature search strategy: 20%
Answer to clinical question: 30%
Presentation (journal club): 25%
Contribution to online discussion, including tasks: 15%

Chief examiner(s)

Workload requirements

Students are expected to allow 10-12 hours per week over the semester in study time.

This unit applies to the following area(s) of study

Prohibitions

VCG5011


6 points, SCA Band 2, 0.125 EFTSL

Refer to the specific census and withdrawal dates for the semester(s) in which this unit is offered, or view unit timetables.

LevelPostgraduate
FacultyFaculty of Pharmacy and Pharmaceutical Sciences
OfferedParkville Second semester 2014 (Off-campus)
Coordinator(s)Dr Rochelle Gellatly

Notes

For postgraduate coursework pharmacy discontinuation dates, please see http://www.pharm.monash.edu.au/students/pg-coursework/unit-discontinuation-dates.html

Quota applies

This unit is quota restricted. Selection is on a first-in, first enrolled basis. For more information please contact the faculty at http://monash.edu/pharm/future/contact/

Synopsis

This unit examines aspects of clinical laboratory data, monitoring patient signs and symptoms and issues in therapeutics. Areas covered include pharmacokinetics, clinical pharmacy, cardiology and topics in general medicine. The focus of these topics is acute care; cases will be hospital rather than community based. Students must be working in a clinical position to undertake this unit and will be required to contribute their own cases.

Outcomes

At completion of this unit it is expected that students will be able to:

  • Describe the pathophysiology of selected disease states and explain the rationale for drug therapy.
  • Describe the therapeutic approach to management of these disease states including reference to the latest available evidence.
  • Discuss the controversies in drug therapy.
  • Comment on new (investigational) approaches to drug therapy.
  • Identify the patient-specific parameters relevant in initiating drug therapy, and monitoring therapy (including alternatives, time-course of clinical and laboratory indices of therapeutic response and adverse effects).
  • Explain clinical interpretation of selected laboratory results in the context of patient monitoring.
  • Understand, define and calculate pharmacokinetic parameters to optimise drug dosing for specific patients.
  • Demonstrate clinical skills relevant to each therapeutic area being studied.

Assessment

Participation in on-line discussion(s): 30% (hurdle)
Assignments: 40%
Submission of a learning portfolio: 30% (hurdle)

Chief examiner(s)

Workload requirements

Students are expected to allow 10-12 hours per week over the semester in study time.

This unit applies to the following area(s) of study

Prerequisites

PGC5001 (VCG5011)

Prohibitions

VCG5021


6 points, SCA Band 2, 0.125 EFTSL

Refer to the specific census and withdrawal dates for the semester(s) in which this unit is offered, or view unit timetables.

LevelPostgraduate
FacultyFaculty of Pharmacy and Pharmaceutical Sciences
OfferedParkville First semester 2014 (Off-campus)
Coordinator(s)Mr John Coutsouvelis

Notes

Quota applies

This unit is quota restricted. Selection is on a first-in, first enrolled basis. For more information please contact the faculty at http://monash.edu/pharm/future/contact/

Synopsis

This unit examines aspects of clinical laboratory data, monitoring patient signs and symptoms and issues in therapeutics. Areas covered include mental health, infectious diseases and topics in general medicine. The focus of these topics is acute care; cases will be hospital rather than community based. Students must be working in a clinical position to undertake this unit and will be required to contribute their own cases.

Outcomes

At completion of this unit it is expected that students will be able to:

  • Describe the pathophysiology of selected disease states and explain the rationale for drug therapy.
  • Describe the therapeutic approach to management of these disease states including reference to the latest available evidence.
  • Discuss the controversies in drug therapy.
  • Comment on new (investigational) approaches to drug therapy.
  • Identify the patient-specific parameters relevant in initiating drug therapy, and monitoring therapy (including alternatives, time-course of clinical and laboratory indices of therapeutic response and adverse effects).
  • Explain clinical interpretation of selected laboratory results in the context of patient monitoring.
  • Understand, define and calculate pharmacokinetic parameters to optimise drug dosing for specific patients.
  • Demonstrate clinical skills relevant to each therapeutic area being studied.

Assessment

Participation in on-line discussion(s): 30% (hurdle)
Assignments: 40%
Submission of a learning portfolio: 30% (hurdle)

Chief examiner(s)

Workload requirements

Students are expected to allow 10-12 hours per week over the semester in study time.

This unit applies to the following area(s) of study

Prerequisites

PGC5002 (VCG5021)

Prohibitions

PGC6003 (VCG5022)


6 points, SCA Band 2, 0.125 EFTSL

Refer to the specific census and withdrawal dates for the semester(s) in which this unit is offered, or view unit timetables.

LevelPostgraduate
FacultyFaculty of Pharmacy and Pharmaceutical Sciences
OfferedParkville Second semester 2014 (Off-campus)
Coordinator(s)Mr John Coutsouvelis

Notes

Quota applies

This unit is quota restricted. Selection is on a first-in, first enrolled basis. For more information please contact the faculty at http://monash.edu/pharm/future/contact/

Synopsis

This unit examines aspects of clinical laboratory data, monitoring patient signs and symptoms and issues in therapeutics. Areas covered are: oncology, emergency medicine, critical care & nephrology. The focus of these topics is acute care; cases will be hospital rather than community based. Students must be working in a clinical position to undertake this unit and will be required to contribute their own cases.

Outcomes

At completion of this unit it is expected that students will be able to:

  • Describe the pathophysiology of selected disease states and explain the rationale for drug therapy.
  • Describe the therapeutic approach to management of these disease states including reference to the latest available evidence.
  • Discuss the controversies in drug therapy.
  • Comment on new (investigational) approaches to drug therapy.
  • Identify the patient-specific parameters relevant in initiating drug therapy, and monitoring therapy (including alternatives, time-course of clinical and laboratory indices of therapeutic response and adverse effects).
  • Explain clinical interpretation of selected laboratory results in the context of patient monitoring.
  • Understand, define and calculate pharmacokinetic parameters to optimise drug dosing for specific patients.
  • Demonstrate clinical skills relevant to each therapeutic area being studied.

Assessment

Participation in on-line discussion(s): 30% (hurdle)
Assignments: 40%
Submission of a learning portfolio: 30% (hurdle)

Chief examiner(s)

Workload requirements

Students are expected to allow 10-12 hours per week over the semester in study time.

This unit applies to the following area(s) of study

Prerequisites

PGC5002 (VCG5021), PGC5003 (PGC6003, VCG5022)

Prohibitions

PGC6004 (VCG6022)


3 points, SCA Band 2, 0.0625 EFTSL

Refer to the specific census and withdrawal dates for the semester(s) in which this unit is offered, or view unit timetables.

LevelPostgraduate
FacultyFaculty of Pharmacy and Pharmaceutical Sciences
OfferedParkville Second semester 2014 (Off-campus)
Coordinator(s)Ms Kirstie Galbraith

Notes

Quota applies

This unit is quota restricted. Selection is on a first-in, first enrolled basis. For more information please contact the faculty at http://monash.edu/pharm/future/contact/

Synopsis

This unit will require each student to present two Journal clubs to the class, following the guidelines introduced in PGC5001 (Evidence based practice). Journal articles for reviews will be clinical trials of therapy and will be assessed according to their validity, importance and applicability. This assessment will incorporate a description of the study design and standard of reporting. Students will be required to present an education session at their workplace on the topic of critical appraisal, run a journal club for their colleagues, and reflect on the experience.

Outcomes

At completion of this unit it is expected that students will be able to:

  • Assess a clinical trial for validity, importance and applicability.
  • Present the results of the assessment in a 20 minute seminar.
  • Discuss the trial in depth and respond to questions generated from the audience.
  • Read the biomedical literature with a critical approach.
  • Demonstrate understanding of critical appraisal and how to teach it.
  • Demonstrate insight into running a journal club in the workplace.

Assessment

Presentation of critical appraisal of journal 1: 25%
Presentation of critical appraisal of journal 2: 25%
Preparation and delivery of teaching session on critical appraisal: 25%
Reflection on running a journal club in the workplace: 25%

Chief examiner(s)

Workload requirements

Students are expected to allow 3-6 hours per week over the semester in study time.

This unit applies to the following area(s) of study

Prerequisites

PGC5001 (VCG5011)

Prohibitions

PGC6005 (VCG6012)


3 points, SCA Band 2, 0.0625 EFTSL

Refer to the specific census and withdrawal dates for the semester(s) in which this unit is offered, or view unit timetables.

LevelPostgraduate
FacultyFaculty of Pharmacy and Pharmaceutical Sciences
OfferedParkville First semester 2014 (Off-campus block of classes)
Parkville Second semester 2014 (Off-campus block of classes)
Coordinator(s)Mr John Coutsouvelis

Notes

Synopsis

This unit provides students with the opportunity to develop their knowledge and skills in an area of specialty practice. It allows them to model their behaviour to provide clinical pharmacy services at a high level, and to become an important member of the healthcare team in a specialty environment.
The student will also put into practice the knowledge and skills learned in Evidence based practice, Clinical pharmacology, Introduction to epidemiology & biostatistics, and Patient data and pharmacotherapy I & II. Students will present a number of case studies highlighting the pharmacist's role in patient management, and the application of evidence based practice.

Outcomes

At completion of this unit it is expected that students will be able to:

  • Describe the pharmacotherapy and patient monitoring relevant to the chosen specialty.
  • Describe useful resources available to pharmacists working in the chosen specialty.
  • Present comprehensive case studies concentrating on the role of the pharmacist in patient management, and the application of evidence based practice.
  • Present a Journal club relevant to the chosen specialty.
  • Present a continuing education lecture on an area of practice or therapeutics relevant to the chosen specialty, and pitched at the right level for the chosen audience.

Assessment

Placement attendance, presentations and submission of learning portfolio (hurdle)

Chief examiner(s)

Off-campus attendance requirements

This unit requires four weeks of placement in a specialty area under the supervision of an experienced specialty clinical pharmacist preceptor approved by the Course Coordinator. The placement organised by the student may be undertaken in a four-week block, or as two blocks each of two weeks.
It is expected that all four weeks will be carried out in the same specialty area of practice. Placements should not generally be undertaken in the student's normal workplace. Students should allocate extra time for reading, case preparation, etc during the placement time.

This unit applies to the following area(s) of study

Prohibitions

PGC6006 (VCG6011)


3 points, SCA Band 2, 0.0625 EFTSL

Refer to the specific census and withdrawal dates for the semester(s) in which this unit is offered, or view unit timetables.

LevelPostgraduate
FacultyFaculty of Pharmacy and Pharmaceutical Sciences
OfferedParkville Second semester 2014 (Off-campus)
Coordinator(s)Dr Rochelle Gellatly

Notes

Quota applies

This unit is quota restricted. Selection is on a first-in, first enrolled basis. For more information please contact the faculty at http://monash.edu/pharm/future/contact/

Synopsis

This unit will enable students to develop their skills in performing practice based research. Didactic lectures will cover topics such as: performing practice based research, writing project/grant proposals and ethics submissions, qualitative versus quantitative research, managing and analysing data. Students enrolled in the Master of Clinical Pharmacy or Master of Wound Care (who are completing this unit as a prerequisite for PGC5008 and PGC5009) will receive detailed information regarding the allocation and roles of supervisors at the University and hospital, as well as the expectations for this series of units.

Outcomes

At the completion of this unit the participant will be able to:

  • Develop a research proposal for a practice based research project.
  • Write a project/grant proposal.
  • Write and submit an ethics proposal.
  • Decide on the correct methodology and analysis for their chosen project.
  • Demonstrate an appropriate level of maturity and independence in developing a practice based research protocol.

Assessment

Class presentation of research project proposal: 30 % (hurdle)
Written submission of proposal and (if required) ethics submission: 50% (hurdle)
Monash supervisor mark: 20%

Chief examiner(s)

Workload requirements

Students are expected to allow 3-6 hours per week over the semester in study time.

This unit applies to the following area(s) of study

Prerequisites

MPH5020 (ECX9720), PGC5001 (VCG5011)
Master of Clinical Pharmacy and Master of Wound Care students must have achieved a minimum grade of 65% in both prerequisites.
Master of Wound Care students must have also successfully completed PGW5101 (PGW1101, VCW1101), PGW5102 (PGW1102, VCW1102), PGW5103 (PGW1103, VCW1103), PGW5104 (PGW1104, VCW1104), PGW5105 (PGW1105, VCW1105), PGW5106 (VCW1106), PGW5108 (VCW1108), PGW5127 (VCW1127)

Prohibitions

PGC6007 (VCG6013), PGW5124 (PGW6124, VCW1124) and PGW5128 (PGW6128, VCW1128)


6 points, SCA Band 2, 0.125 EFTSL

Refer to the specific census and withdrawal dates for the semester(s) in which this unit is offered, or view unit timetables.

LevelPostgraduate
FacultyFaculty of Pharmacy and Pharmaceutical Sciences
OfferedParkville First semester 2014 (Off-campus)
Coordinator(s)Mr John Coutsouvelis

Notes

Quota applies

This unit is quota restricted. Selection is on a first-in, first enrolled basis. For more information please contact the faculty at http://monash.edu/pharm/future/contact/

Synopsis

This unit will enable students to consolidate their skills in performing practice based research. There will be limited didactic lectures with the majority of time allocated to collection of data consistent with the methodology developed in Introduction to clinical research. The research project will be completed in Clinical research 3.

Outcomes

At the completion of this unit the participant will be able to:

  • Gain ethics approval from their practice site and from Monash University.
  • Collect data according to methodology developed in PGC5007 Introduction to clinical research, for subsequent appropriate analysis.
  • Present work in progress to a panel.
  • Demonstrate an appropriate level of maturity and independence in performing practice based research.

Assessment

Successful attainment of ethics approval from practice site pass/fail. A pass in this assessment task is required for an overall pass in this unit. (hurdle)
Successful attainment of ethics approval from Monash University pass/fail. A pass in this assessment task is required for an overall pass in this unit. (hurdle)
Literature Review: 30%. This is the critical review of the literature which will form the basis and rationale for the student's research protocol. It will cover background information and analyse similar research which has been published, emphasising the need for the current research.
Class presentation of work in progress: 50%. This verbal presentation will describe the work undertaken in the data collection phase of the project and the raw data obtained. Some analysis may also be presented. The work will be assessed by a panel of staff members from the Department of Pharmacy Practice, and a selection of practicing healtcare professionals (eg. pharmacists, nurses). (hurdle)
Monash Supervisor mark: 20%. This mark will reflect the student's interaction with their supervisor eg: independence, ability to act on feedback, planning, etc.

Chief examiner(s)

Workload requirements

Students are expected to allow 10-12 hours per week over the semester in study time.

This unit applies to the following area(s) of study

Prerequisites

PGC5007 (PGC6007, VCG6013)

Prohibitions

PGC6008 (VCG6021), PGW6124 (VCW1124), PGW6128 (VCW1128)


3 points, SCA Band 2, 0.0625 EFTSL

Refer to the specific census and withdrawal dates for the semester(s) in which this unit is offered, or view unit timetables.

LevelPostgraduate
FacultyFaculty of Pharmacy and Pharmaceutical Sciences
OfferedParkville Second semester 2014 (Off-campus)
Coordinator(s)Mr John Coutsouvelis

Notes

Quota applies

This unit is quota restricted. Selection is on a first-in, first enrolled basis. For more information please contact the faculty at http://monash.edu/pharm/future/contact/

Synopsis

This unit is a natural progression from PGC5008 and will allow students to further consolidate their research skills. Emphasis is on data analysis, drawing conclusions from the research, and development of the final research report. The final report will involve a verbal presentation of the entire project, and submission of a written report.

Outcomes

At the completion of this unit the participant will be able to:

  • Analyse data in a manner appropriate to the chosen study design and results obtained.
  • Draw conclusions from the results obtained.
  • Present a verbal report of the research undertaken.
  • Submit a written report of their research project.
  • Demonstrate an appropriate level of maturity and independence in performing practice based research.

Assessment

Class presentation of research project (20 minute): 30% (hurdle)
Written submission of research project: 50% (hurdle)
Monash supervisor mark: 20%

Chief examiner(s)

Workload requirements

Students are expected to allow 3-6 hours per week over the semester in study time.

This unit applies to the following area(s) of study

Prerequisites

PGC5007 (PGC6007, VCG6013), PGC5008 (PGC6008, VCG6021)

Prohibitions

PGC6009 (VCG6023), PGW6128 (VCW1128)


6 points, SCA Band 2, 0.125 EFTSL

Refer to the specific census and withdrawal dates for the semester(s) in which this unit is offered, or view unit timetables.

LevelPostgraduate
FacultyFaculty of Pharmacy and Pharmaceutical Sciences
OfferedParkville First semester 2014 (Off-campus)
Parkville Second semester 2014 (Off-campus)
Coordinator(s)Ms Sharmila Khumra

Notes

Quota applies

This unit is quota restricted. Selection is on a first-in, first enrolled basis. For more information please contact the faculty at http://monash.edu/pharm/future/contact/

Synopsis

This unit will provide a broad overview or introduction to the treatment and management of infectious diseases. The focus will be on common infections seen in community and hospital settings, principles of microbiology and infectious diseases, antimicrobial use, and antimicrobial stewardship. The broad unit objectives are for students to develop and apply infectious diseases and antimicrobial use knowledge and skills in the care of patients, especially those with infections. These may be patients in the community or hospital settings. The knowledge and skills developed will be at a general level rather than at the level required for a specialist infectious diseases pharmacist.

Outcomes

On completion of the unit students will be able to:

  • Prepare and analyse treatment plans that optimise the use of anti-infectives.
  • Recommend approaches to manage patients requiring anti-infective therapies.
  • Demonstrate critical thinking, communication skills relevant to peers and patients and problem-solving, with a focus on infectious diseases related and anti-infectives related topics.

Assessment

Assignment 1: 25%
Assignment 2: 25%
Contribution to on-line discussions: 30%
Submission of a learning portfolio: 20% (hurdle)

Chief examiner(s)

Workload requirements

Students are expected to allow 10-12 hours per week over the semester in study time.

This unit applies to the following area(s) of study

Prerequisites

There are no prerequisites however it is preferable for students to have completed PGC5001 Evidence based practice prior to enrolling into this unit.

Prohibitions

This unit cannot be taken with PGC5003 Patient data and pharmacotherapy 2 without prior approval from the relevant Course Director as there is significant overlap in content.


6 points, SCA Band 2, 0.125 EFTSL

Refer to the specific census and withdrawal dates for the semester(s) in which this unit is offered, or view unit timetables.

LevelPostgraduate
FacultyFaculty of Pharmacy and Pharmaceutical Sciences
OfferedParkville First semester 2014 (Off-campus)
Parkville Second semester 2014 (Off-campus)
Coordinator(s)Ms Angela Calandra

Notes

For postgraduate coursework pharmacy discontinuation dates, please see http://www.pharm.monash.edu.au/students/pg-coursework/unit-discontinuation-dates.html

Quota applies

This unit is quota restricted. Selection is on a first-in, first enrolled basis. For more information please contact the faculty at http://monash.edu/pharm/future/contact/

Synopsis

Dermatology is an elective unit offered as part of the Graduate Certificate in Pharmacy Practice and the Master of Pharmacy Practice. Students will develop an in depth knowledge of the identification and management of common dermatological problems, especially those encountered in primary care and therefore increase their confidence in dealing with these problems.

Prescribed Text:
Skin Disease- Diagnosis and Treatment by Thomas P Habif
3edn
ISBN 978-0-323-07700-2

Outcomes

At the completion of this unit students will be able to:

  • Understand common morphological terms used in dermatology, and use these terms to describe dermatological lesions.
  • Appreciate the differences between vehicles used in the treatment of dermatological conditions and choose an appropriate vehicle to treat skin conditions.
  • Confidently diagnose and treat common skin infections.
  • Understand the underlying pathology of inflammatory skin conditions such as acne, dermatitis, rosacea and psoriasis and appreciate the variety of treatment regimes available to treat these skin conditions.
  • Confidently identify (and where applicable treat) a number of miscellaneous skin conditions such as alopecia, hyperhidrosis, disorders of pigmentation and drug induced reactions.

Assessment

Online discussion: 40%
Quizzes: 40% (hurdle)
Case studies: 20% (hurdle)

Chief examiner(s)

Workload requirements

Students are expected to allow 10-12 hours per week over the semester in study time.

This unit applies to the following area(s) of study

Prohibitions

VCP5013


3 points, SCA Band 2, 0.0625 EFTSL

Refer to the specific census and withdrawal dates for the semester(s) in which this unit is offered, or view unit timetables.

LevelPostgraduate
FacultyFaculty of Pharmacy and Pharmaceutical Sciences
OfferedParkville Second semester 2014 (Off-campus)
Coordinator(s)Ms Laura Dean

Notes

For postgraduate coursework pharmacy discontinuation dates, please see http://www.pharm.monash.edu.au/students/pg-coursework/unit-discontinuation-dates.html

Quota applies

This unit is quota restricted. Selection is on a first-in, first enrolled basis. For more information please contact the faculty at http://monash.edu/pharm/future/contact/

Synopsis

The overall aim of this unit is to provide a theoretical framework and support for practitioners willing to take on the important role of clinical educator (preceptor) for health care discipline undergraduates and graduates. It covers a variety of topics relating to clinical education exploring the importance clinical education has in developing professional competence in beginning health science practitioners. It considers the various roles you fulfil as a health science professional. Learning in clinical settings explores how students and new graduates learn as well as what they learn, including cognitive and organisational psychology, higher education and professional education. The relationship between clinical educators and learners during clinical placements and issues around learning in the workplace are covered, including legal and ethical issues related to learners' participation in clinical settings. The differences between the clinical educator role and mentoring role are explored with both formal and informal mentoring relationships and their benefits and potential pitfalls.

Outcomes

On completion of this unit the student will be able to:

  • Clarify their role as a clinical educator.
  • Review personal expectations of the role of a clinical educator.
  • Identify the benefits of being a clinical educator.
  • Explore the characteristics of an effective clinical teacher.
  • Recognise professional issues that impact on the clinical educator role.
  • Recognise the need to evaluate clinical education and identify potential evaluation strategies.
  • Clarify the learning process as an individual search for meaning.
  • Present a model of experiential learning.
  • Explore individual preferences for different learning activities.
  • Explore the domains of learning underpinning professional competencies.
  • Recognise the relationship assessment has on motivation for the learning task.
  • Explain learning activities and methods which encourage self directed learning.
  • Highlight the importance of reflection and suggest activities which encourage learners to reflect.
  • List the roles of the clinical educator.
  • Explore personal attributes which impact on the clinical educator role.
  • Apply a framework for managing different phases of the clinical placement.
  • Explore the tasks associated with the roles of the clinical educator.
  • Identify strategies for developing a positive working learner/clinical educator relationship.
  • Explore individual differences (e.g. age, gender, culture) as they impact on clinical education.
  • Implement effective group management skills.
  • Apply a problem solving approach to potential learner-clinical educator difficulties.
  • Use a framework (based on social learning theory) to develop competence as a clinical educator.
  • Develop clinical education skills and activities that are relevant to the context of the workplace.
  • Explore ethical and legal issues related to the workplace.
  • Describe the mentoring process.
  • Modify the mentoring process to meet individual requirements.
  • Compare the similarities and differences between the role of mentor and clinical educator.
  • Recognise the importance of looking after yourself and avoiding burnout.
  • List the benefits and limitations of mentoring.
  • Identify the skills required to manage each phase of the mentoring process.

Assessment

Online tasks (e.g.: contribution to online discussion and shared exercises): 60%
Written assignment: 40%

Chief examiner(s)

Workload requirements

Students are expected to allow 3-6 hours per week over the semester in study time.

This unit applies to the following area(s) of study


6 points, SCA Band 2, 0.125 EFTSL

Refer to the specific census and withdrawal dates for the semester(s) in which this unit is offered, or view unit timetables.

LevelPostgraduate
FacultyFaculty of Pharmacy and Pharmaceutical Sciences
OfferedParkville First semester 2014 (Off-campus)
Parkville Second semester 2014 (Off-campus)
Coordinator(s)Mr Rohan Elliott; Ms Elizabeth Morabito

Notes

For postgraduate coursework pharmacy discontinuation dates, please see http://www.pharm.monash.edu.au/students/pg-coursework/unit-discontinuation-dates.html

Quota applies

This unit is quota restricted. Selection is on a first-in, first enrolled basis. For more information please contact the faculty at http://monash.edu/pharm/future/contact/

Synopsis

Geriatric pharmacy practice is an elective unit in the Masters and Graduate Certificate in Pharmacy Practice. The unit will help students develop specialist knowledge and skills in geriatric pharmacy practice and medication management reviews. The unit explores medication management for elderly patients in community, residential aged care and hospitals settings, through readings, case studies, online small group discussions and fieldwork as outlined below.

Outcomes

After completing this unit, students will be able to:

  • Describe physiological and pathophysiological changes that occur in the ageing population.
  • Describe the principles of prescribing and medication management in older patients.
  • Identify and manage medication related problems in older patients.
  • Conduct medication management interviews with elderly patients.
  • Write professional medication management review reports.
  • Navigate the Aged Care system and refer patient's to relevant health care services where appropriate.

Fieldwork

Patient medication history interview and medication review to be conducted in students' workplace. Home Medicines Review to be conducted under the supervision of an accredited consultant pharmacist or hospital outreach pharmacist (assistance is available with organising this for students located in Victoria, if the student does not have access to a suitably experienced pharmacist).

Assessment

Online tasks (e.g. online discussions, online quizzes): 40%
Written assignments (including written medication management reviews and completion of fieldwork as described above): 60%

Chief examiner(s)

Mr Rohan Elliott; Ms Elizabeth Morabito

Workload requirements

Student are expected to allow 10-12 hours per week over the semester in study time.

This unit applies to the following area(s) of study

Prohibitions

VCP5015


6 points, SCA Band 2, 0.125 EFTSL

Refer to the specific census and withdrawal dates for the semester(s) in which this unit is offered, or view unit timetables.

LevelPostgraduate
FacultyFaculty of Pharmacy and Pharmaceutical Sciences
OfferedParkville Second semester 2014 (Off-campus)
Coordinator(s)Mr Rohan Elliott

Notes

For postgraduate coursework pharmacy discontinuation dates, please see http://www.pharm.monash.edu.au/students/pg-coursework/unit-discontinuation-dates.html

Quota applies

This unit is quota restricted. Selection is on a first-in, first enrolled basis. For more information please contact the faculty at http://monash.edu/pharm/future/contact/

Synopsis

Geriatric disease state management is an elective unit in the Master of and Graduate Certificate in Pharmacy Practice. The unit will help students develop specialist knowledge and skills in the management of major diseases and syndromes affecting older people. In particular it will focus on medication-related issues and the role of the pharmacist, including medication management reviews in patients with these conditions.

Outcomes

After completing this unit, students should be able to:

  • Describe the effects of ageing and disease on cognitive function, falls and balance, bone health, bladder and bowel function and pain.
  • Recognise the signs and symptoms of cognitive disorders, falls, dizziness, osteoporosis, bladder and bowel problems and pain in older people.
  • Identify patients who are at increased risk of developing the aforementioned problems.
  • Identify potential medication-related causes of cognitive impairment, falls, dizziness, osteoporosis, and bladder and bowel problems.
  • Recommend appropriate pharmacological and non-pharmacological management for prevention and management of cognitive disorders, falls, dizziness, osteoporosis, bladder and bowel problems and pain.
  • Prepare management plans and medication management reports for elderly patients with the aforementioned problems.

Assessment

Assessment tasks include:
Case studies and online discussions: 40%
Written assignments, medication management reports and online quizzes: 60%

Chief examiner(s)

Workload requirements

Student are expected to allow 10-12 hours per week over the semester in study time.

This unit applies to the following area(s) of study

Co-requisites

PGP5015 (VCP5015)

Prohibitions

VCP5016


6 points, SCA Band 2, 0.125 EFTSL

Refer to the specific census and withdrawal dates for the semester(s) in which this unit is offered, or view unit timetables.

LevelPostgraduate
FacultyFaculty of Pharmacy and Pharmaceutical Sciences
OfferedParkville First semester 2014 (Off-campus)
Parkville Second semester 2014 (Off-campus)
Coordinator(s)Ms Elizabeth Morabito

Notes

For postgraduate coursework pharmacy discontinuation dates, please see http://www.pharm.monash.edu.au/students/pg-coursework/unit-discontinuation-dates.html

Quota applies

This unit is quota restricted. Selection is on a first-in, first enrolled basis. For more information please contact the faculty at http://monash.edu/pharm/future/contact/

Synopsis

The Mental Health unit covers the aetiology, pathophysiology, diagnosis, treatment and monitoring of the following common mental health problems:

  • anxiety & obsessional disorders
  • depression
  • schizophrenia
  • bipolar disorders
  • other conditions ( Attention Deficit Hyperactivity Disorder (ADHD), postpartum depression & psychosis).

The unit will focus particularly on medication management issues in patients with these conditions and the pharmacist's role in managing these patients. The unit will also give an overview of the mental health care system in Australia.

Outcomes

The unit focusses on medication-related issues and the pharmacist's role, associated in the care of patients with mental health conditions. On completion of the unit students will be able to:

  • Demonstrate knowledge of mental health conditions and associated treatments.
  • Apply this knowledge to cases studies of mental health patient.
  • Critically evaluate currently available treatments (pharmacological and non-pharmacological) used in the management of patients with these mental health conditions.

Assessment

Online tasks (participation in online discussions): 50%
Written assignments (case study(s) and essay(s)): 50%

Chief examiner(s)

Workload requirements

Students are expected to allow 10-12 hours per week over the semester in study time.

This unit applies to the following area(s) of study

Prohibitions

VCP5017


6 points, SCA Band 2, 0.125 EFTSL

Refer to the specific census and withdrawal dates for the semester(s) in which this unit is offered, or view unit timetables.

LevelPostgraduate
FacultyFaculty of Pharmacy and Pharmaceutical Sciences
OfferedParkville First semester 2014 (Off-campus)
Coordinator(s)Ms Laura Dean

Notes

For postgraduate coursework pharmacy discontinuation dates, please see http://www.pharm.monash.edu.au/students/pg-coursework/unit-discontinuation-dates.html

Quota applies

This unit is quota restricted. Selection is on a first-in, first enrolled basis. For more information please contact the faculty at http://monash.edu/pharm/future/contact/

Synopsis

The unit will cover the clinical and non-clinical topics listed below, enabling appropriate pharmacist management of palliative care patients.

Clinical topics:

  • management of pain
  • management of symptoms other than pain
  • palliative care in malignant and non-malignant disease
  • prescribing in palliative care

Non-clinical topics:

  • palliative care principles
  • ethical issues
  • access to palliative care medications
  • introduction to the Australian palliative care system

Pharmacists completing this unit will acquire knowledge about current therapies used in symptom management with the aim of achieving the best possible quality of life for palliative care patients and their families.

Outcomes

At the completion of this unit students will be able to:

  • Describe the principles of palliative care.
  • Discuss the multi-disciplinary approach to palliative care within the Australian palliative care system.
  • Apply pharmacological and non-pharmacological pain management knowledge to their professional practice.
  • Recognise, monitor, and pharmacologically and non-pharmacologically manage common non-pain symptoms and treatment side-effects.
  • Have a working knowledge of how palliative cancer care medicines can be administered and accessed.
  • Apply the principles of prescribing and de-prescribing in palliative care.

Assessment

Contributions to case studies in online moderated discussion forums: 50%
Written assignment 1: 10%
Written assignment 2: 10%
Case study 1: 10%
Case study 2: 10% (hurdle)
Submission of a learning portfolio: 10% (hurdle)

Chief examiner(s)

Workload requirements

Student are expected to allow 10-12 hours per week over the semester in study time.

This unit applies to the following area(s) of study


6 points, SCA Band 2, 0.125 EFTSL

Refer to the specific census and withdrawal dates for the semester(s) in which this unit is offered, or view unit timetables.

LevelPostgraduate
FacultyFaculty of Pharmacy and Pharmaceutical Sciences
Monash Passport categoryInternship (Act Program)
OfferedParkville First semester (extended) 2014 (Off-campus)
Coordinator(s)Ms Michelle Vienet

Notes

Synopsis

Further development of the technical, clinical, personal and professional skills acquired as a pharmacy graduate that form the basis of future practice. The unit explores the day-to-day practice of pharmacy including systematic problem solving, therapeutics, evidence based practice, patient monitoring and outcomes, symptomology, improving adherence, multiple medication management, pharmaceutical care, standards and competencies for pharmacy practice, ethics, legal aspects, multidisciplinary approaches to health care, primary care, over the counter medicines, communication and counselling, public health, pharmaceutical calculations, risk management and dealing with difficult clients.

Outcomes

At the completion of this unit students will be able to:

  • Demonstrate a sound understanding of the legal, professional and ethical framework for pharmacy practice in Australia.
  • Demonstrate strong problem solving skills and apply professional judgement in a range of areas including prescription problems, therapeutic problems, and legal and ethical problems.
  • Apply evidence-based principles to the practice of pharmacy.
  • Promote and contribute to optimal use of medicines.
  • Provide primary health care, including: identifying symptoms, knowing when to refer patients for medical evaluation, and recommending appropriate non-prescription products.
  • Effectively communicate medication-related information to patients and other health professionals.
  • Solve simple and complex pharmaceutical calculations.
  • Understand the nature and importance of multi-disciplinary care.
  • Apply organisational skills and manage work issues and interpersonal relationships in pharmacy practice.

Fieldwork

Students enrolled in this unit must hold provisional registration with the Pharmacy Board of Australia and be undertaking an approved placement. Students who fail to gain provisional registration, or who have their registration rescinded during the program, will be unable to continue in this unit.

Assessment

Assessment is by seminar attendance, online discussion group participation, online quizzes and submission of a learning portfolio including a record of Continuing Professional Development (CPD and participation in National Prescribing Service activities). (hurdle)

Chief examiner(s)

Off-campus attendance requirements

Students are required to attend two on campus seminars by 2 days each semester (total 4 days per semester). As a guide, it would be expected that graduates completing the Internship program should be completing a minimum of about 2-3 hours per week study time in addition to attendance at seminars and CPD requirements.

This unit applies to the following area(s) of study

Prohibitions

PGP5011 (VCP5011)


6 points, SCA Band 2, 0.125 EFTSL

Refer to the specific census and withdrawal dates for the semester(s) in which this unit is offered, or view unit timetables.

LevelPostgraduate
FacultyFaculty of Pharmacy and Pharmaceutical Sciences
Monash Passport categoryInternship (Act Program)
OfferedParkville Term 3 2014 (Off-campus)
Coordinator(s)Ms Michelle Vienet

Notes

Synopsis

Further development of the technical, clinical, personal and professional skills acquired as a pharmacy graduate that form the basis of future practice. The unit explores the day-to-day practice of pharmacy including systematic problem solving, therapeutics, evidence based practice, patient monitoring and outcomes, symptomology, improving adherence, multiple medication management, pharmaceutical care, standards and competencies for pharmacy practice, ethics, legal aspects, multidisciplinary approaches to health care, primary care, over the counter medicines, communication and counselling, public health, pharmaceutical calculations, risk management and dealing with difficult clients.

Outcomes

At the completion of this unit students will be able to:

  • Demonstrate a sound understanding of the legal, professional and ethical framework for pharmacy practice in Australia.
  • Demonstrate strong problem solving skills and apply professional judgement in a range of areas including prescription problems, therapeutic problems, and legal and ethical problems.
  • Apply evidence-based principles to the practice of pharmacy.
  • Promote and contribute to optimal use of medicines.
  • Provide primary health care, including: identifying symptoms, knowing when to refer patients for medical evaluation, and recommending appropriate non-prescription products.
  • Effectively communicate medication-related information to patients and other health professionals.
  • Solve simple and complex pharmaceutical calculations.
  • Understand the nature and importance of multi-disciplinary care.
  • Apply organisational skills and manage work issues and interpersonal relationships in pharmacy practice.

Fieldwork

Students enrolled in this unit must hold provisional registration with the Pharmacy Board of Australia and be undertaking an approved placement. Students who fail to gain provisional registration, or who have their registration rescinded during the program, will be unable to continue in this unit.

Assessment

Assessment is by seminar attendance, online discussion group participation, online quizzes and submission of a learning portfolio including a record of Continuing Professional Development (CPD and participation in National Prescribing Service activities). (hurdle)

Chief examiner(s)

Off-campus attendance requirements

Students are required to attend two on campus seminars of 2 days each semester ( a total of 4 days per semester). As a guide, it would be expected that graduates completing the Internship program should be completing a minimum of about 2-3 hours per week, in addition to attendance at seminars and CPD requirements.

This unit applies to the following area(s) of study

Prohibitions

PGP5012 (VCG5012)


3 points, SCA Band 2, 0.0625 EFTSL

Refer to the specific census and withdrawal dates for the semester(s) in which this unit is offered, or view unit timetables.

LevelPostgraduate
FacultyFaculty of Pharmacy and Pharmaceutical Sciences
OfferedParkville First semester 2014 (Off-campus)
Parkville Term 3 2014 (Off-campus)
Coordinator(s)Ms Adriana Tiziani

Notes

Quota applies

This unit is quota restricted. Selection is on a first-in, first enrolled basis. For more information please contact the faculty at http://www.monash.edu.au/pharm/future/contact/

Synopsis

This unit will describe the anatomy and physiology of normal tissue structure and outline the physiology, process and types of wound healing. It will explore the general principles necessary to achieve better wound healing as well as the intrinsic and extrinsic factors that affect wound healing.

Outcomes

At the completion of this unit students will be able to:

  • Describe anatomy and physiology of normal tissue structure.
  • Describe the physiology of wound healing.
  • Demonstrate an understanding of wound healing across the age continuum.
  • Identify local and systemic factors that promote or impede wound healing.
  • Recognise different phases of wound healing and explain factors that may impact on the progression of healing.

Assessment

Minor assignment: 30%
Major written assignment: 60% (hurdle)
Participation in online tutorials: 10%

Chief examiner(s)

Workload requirements

Students are expected to allow 3- 6 hours per week over the semester in study time.

This unit applies to the following area(s) of study

Prohibitions

PGW1101 (VCW1101)


6 points, SCA Band 2, 0.125 EFTSL

Refer to the specific census and withdrawal dates for the semester(s) in which this unit is offered, or view unit timetables.

LevelPostgraduate
FacultyFaculty of Pharmacy and Pharmaceutical Sciences
OfferedParkville First semester 2014 (Off-campus)
Parkville Second semester 2014 (Off-campus)
Coordinator(s)Ms Adriana Tiziani

Notes

Quota applies

This unit is quota restricted. Selection is on a first-in, first enrolled basis. For more information please contact the faculty at http://www.monash.edu.au/pharm/future/contact/

Synopsis

Wound assessment is an integral component of the overall plan to effectively manage the wound healing process. To be able to effectively conduct an assessment of an acute/chronic wound, it is important that the clinician has a clear understanding of the client's personal environment along with the underlying aetiology and characteristics of the wound. This subject aims to provide a comprehensive framework for wound assessment that underpins all other units within the course.

Outcomes

At the completion of this unit students will be able to:

  • Identify the components of a wound assessment in the context of the whole person.
  • Discuss client characteristics relevant to wound healing.
  • Identify and discuss specific characteristics of a wound.
  • Utilise a wound assessment framework to diagnose and describe a wound.
  • Describe the stages and/or classifications of wounds.
  • Identify and discuss criteria used to monitor wound progress.
  • Use a wound assessment chart to interpret and communicate the progress of a wound.

Assessment

Two minor assignments: 30%
Major written assignment: 50% (hurdle)
Participation in online tutorials: 20%

Chief examiner(s)

Workload requirements

Students are expected to allow 10-12 hours per week over the semester in study time.

This unit applies to the following area(s) of study

Prohibitions

PGW1102 (VCW1102)


3 points, SCA Band 2, 0.0625 EFTSL

Refer to the specific census and withdrawal dates for the semester(s) in which this unit is offered, or view unit timetables.

LevelPostgraduate
FacultyFaculty of Pharmacy and Pharmaceutical Sciences
OfferedParkville Term 2 2014 (Off-campus)
Parkville Trimester 3 2014 (Off-campus)
Coordinator(s)Ms Adriana Tiziani

Notes

Quota applies

This unit is quota restricted. Selection is on a first-in, first enrolled basis. For more information please contact the faculty at http://www.monash.edu.au/pharm/future/contact/

Synopsis

A wound dressing is a therapeutic agent and the choice of dressing will aid in optimising wound healing. Unfortunately, there is no such thing as a universal dressing. Each wound is unique. This unit will provide students with an increased understanding of the history and advances of wound dressings and include the classification, properties and application of modern wound dressing.

Outcomes

At the completion of this unit students will be able to:

  • Explain a basic history and development of wound dressings.
  • Identify the classification and properties of modern wound dressings.
  • Demonstrate and justify the selection of appropriate dressing products for different wounds.
  • Explain the composition, structure and use of wound dressing products.
  • Explain the role of antimicrobial and antibiotic agents in wound care.
  • Demonstrate an understanding of new technologies in wound dressings.

Assessment

Minor Assignment: 30%
Major written assignment: 60% (hurdle)
Participation in online tutorials: 10%

Chief examiner(s)

Workload requirements

Students are expected to allow 3- 6 hours per week over the semester in study time.

This unit applies to the following area(s) of study

Co-requisites

PGW5102 (PGW1102, VCW1102) Pharmacy practice students taking this unit as an elective, will not be required to be enrolled or have completed the co-requisite unit.

Prohibitions

PGW5103 (VCW1103)


3 points, SCA Band 2, 0.0625 EFTSL

Refer to the specific census and withdrawal dates for the semester(s) in which this unit is offered, or view unit timetables.

LevelPostgraduate
FacultyFaculty of Pharmacy and Pharmaceutical Sciences
OfferedParkville First semester 2014 (Off-campus)
Parkville Term 3 2014 (Off-campus)
Coordinator(s)Ms Adriana Tiziani

Notes

Quota applies

This unit is quota restricted. Selection is on a first-in, first enrolled basis. For more information please contact the faculty at http://www.monash.edu.au/pharm/future/contact/

Synopsis

This unit provides students with a greater understanding and skills to effectively manage acute wounds such as surgical wounds, thermal injuries and traumatic wounds. Students will gain a broader understanding of techniques used to assess acute wounds, the role of infection, exudate production, and how to achieve better health outcomes, preventing complications, limiting scarring and restoring normal activities.

Outcomes

At the completion of this unit students will be able to:

  • Identify and describe the types of acute wounds.
  • Demonstrate an understanding of the factors that may delay or interfere with healing of acute wounds and potentially lead to chronicity.
  • Discuss infection in acute wounds and strategies for prevention.
  • Investigate methods of turning chronic into acute wounds.
  • Discuss wound closure techniques, methods and materials.
  • Examine techniques in the management of acute wounds, including various forms of wound debridement and topical negative pressure.

Assessment

Minor assignment: 30%
Major written assignment: 60% (hurdle)
Participation in online tutorials: 10%

Chief examiner(s)

Workload requirements

Students are expected to allow 3- 6 hours per week over the semester in study time.

This unit applies to the following area(s) of study

Co-requisites

PGW5102 (PGW1102, VCW1102), PGW5103 (PGW1103, VCW1103)
Pharmacy practice students taking this unit as an elective, will not be required to be enrolled or have completed the co-requisite units.

Prohibitions

PGW1104 (VCW1104)


3 points, SCA Band 2, 0.0625 EFTSL

Refer to the specific census and withdrawal dates for the semester(s) in which this unit is offered, or view unit timetables.

LevelPostgraduate
FacultyFaculty of Pharmacy and Pharmaceutical Sciences
OfferedParkville Term 2 2014 (Off-campus)
Parkville Trimester 3 2014 (Off-campus)
Coordinator(s)Ms Adriana Tiziani

Notes

Quota applies

This unit is quota restricted. Selection is on a first-in, first enrolled basis. For more information please contact the faculty at http://www.monash.edu.au/pharm/future/contact/

Synopsis

This unit is designed to provide students with knowledge and skills to recognise and effectively manage chronic wounds. Students will consider chronic wounds such as pressure ulcers, diabetic foot and leg ulcers and investigate these in relation to their incidence in the community, causes and predisposing risk factors, strategies to reduce or eliminate causes, short and long term management.

Outcomes

At the completion of this unit students will be able to:

  • Recognise the incidence and significance of chronic wounds in the community.
  • Demonstrate an understanding of the aetiology of chronic wounds.
  • Explain the types of factors that lead to chronicity in relation to wound factors, client factors, inappropriate treatment.
  • Discuss the process of review and management of chronic wounds.
  • Discuss the principles of maintenance and prevention of recurrence.

Assessment

Minor assignment: 30%
Major written assignment: 60% (hurdle)
Participation in online tutorials: 10%

Chief examiner(s)

Workload requirements

Students are expected to allow 3- 6 hours per week over the semester in study time.

This unit applies to the following area(s) of study

Co-requisites

PGW5102 (PGW1102, VCW1102), PGW5103 (PGW1103, VCW1103)
Pharmacy practice students taking this unit as an elective, will not be required to be enrolled or have completed the co-requisite unit.

Prohibitions

PGW1105 (VCW1105)


3 points, SCA Band 2, 0.0625 EFTSL

Refer to the specific census and withdrawal dates for the semester(s) in which this unit is offered, or view unit timetables.

LevelPostgraduate
FacultyFaculty of Pharmacy and Pharmaceutical Sciences
OfferedParkville First semester 2014 (Off-campus)
Coordinator(s)Ms Adriana Tiziani

Notes

For postgraduate coursework pharmacy discontinuation dates, please see http://www.pharm.monash.edu.au/students/pg-coursework/unit-discontinuation-dates.html

Quota applies

This unit is quota restricted. Selection is on a first-in, first enrolled basis. For more information please contact the faculty at http://www.monash.edu.au/pharm/future/contact/

Synopsis

The unit will examine the effect of systemic medication on wound healing. A number of specific drug classes will be described and discussed in relation to wound healing looking especially at current evidence to support theoretical knowledge. Furthermore, medications used to treat wound complications such as infection and pain will be explored.

Outcomes

At the completion of this unit students will be able to:

  • Discuss common assumptions about medications and wound healing.
  • Differentiate between medication, drug, medicine and nutrient and demonstrate an understanding medication classification.
  • List the routes of medication administration and discuss the implications for absorption and effectiveness.
  • Discuss pharmacokinetics and pharmacodynamics.
  • Demonstrate an understanding of evidence based practice and its relationship to medication and wound healing.
  • Discuss common assumptions of how a medication may impact on wound healing.
  • Explore the theoretical rationale and clinical evidence of the impact of the following on wound healing:
    1. ) corticosteroids
    2. ) non-steroidal anti-inflammatory drugs (NSAIDs)
    3. ) immunomodulating agents
    4. ) cigarette smoking
    5. ) pentoxifylline
      • Use a systematic approach to critically appraise the clinical evidence on other agents such as phenytoin, oestrogen, dapsone, colchicine and anticoagulants.
      • Discuss the role of antibiotics in the management of wound infection.
      • Discuss the management of pain associated with wounds, including:
        1. ) types of pain
        2. ) pain assessment
        3. ) pain management using pharmacological and non-pharmacological methods
          • Discuss the role of nutritional supplementation in wound healing.

Assessment

Minor assignment: 30%
Major written assignment: 60% (hurdle)
Participation in online tutorials: 10%

Chief examiner(s)

Workload requirements

Students are expected to allow 3- 6 hours per week over the semester in study time.

This unit applies to the following area(s) of study

Prerequisites

PGW5101 (PGW1101, VCW1101), PGW5102 (PGW1102, VCW1102), PGW5103 (PGW1103, VCW1103), PGW5104 (PGW1104, VCW1104), PGW5105 (PGW1105, VCW1105) Pharmacy practice students taking this unit as an elective, will not be required to be enrolled or have completed the co-requisite units.

Prohibitions

VCW1106


3 points, SCA Band 2, 0.0625 EFTSL

Refer to the specific census and withdrawal dates for the semester(s) in which this unit is offered, or view unit timetables.

LevelPostgraduate
FacultyFaculty of Pharmacy and Pharmaceutical Sciences
OfferedParkville Term 2 2014 (Off-campus)
Coordinator(s)Ms Adriana Tiziani

Notes

For postgraduate coursework pharmacy discontinuation dates, please see http://www.pharm.monash.edu.au/students/pg-coursework/unit-discontinuation-dates.html

Quota applies

This unit is quota restricted. Selection is on a first-in, first enrolled basis. For more information please contact the faculty at http://www.monash.edu.au/pharm/future/contact/

Synopsis

This unit will explore the importance of nutrition in wound healing. Nutritional assessment, management and treatment of nutritional deficiencies will be described and discussed in relation to wound healing.

Outcomes

At the completion of this unit students will be able to:

  • Demonstrate a comprehension of normal digestive processes, the sources of macro and micronutrients and their roles in body metabolism.
  • Explain malnutrition status and how these can be reversed.
  • Assess nutritional status and be aware of advantages and disadvantages of the variety of methods for doing so.
  • Describe the different methods of enrichment and delivery of nutrition and supplements.
  • Correlate nutritional requirements to specific wound states, such as pressure ulcers.

Assessment

Minor assignment: 30%
Major written assignment: 60% (hurdle)
Participation in online tutorials: 10%

Chief examiner(s)

Workload requirements

Students are expected to allow 3- 6 hours per week over the semester in study time.

This unit applies to the following area(s) of study

Prerequisites

PGW5101 (PGW1101, VCW1101), PGW5102 (PGW1102, VCW1102), PGW5103 (PGW1103, VCW1103), PGW5104 (PGW1104, VCW1104), PGW5105 (PGW1105, VCW1105)

Prohibitions

VCW1108


3 points, SCA Band 2, 0.0625 EFTSL

Refer to the specific census and withdrawal dates for the semester(s) in which this unit is offered, or view unit timetables.

LevelPostgraduate
FacultyFaculty of Pharmacy and Pharmaceutical Sciences
OfferedParkville First semester 2014 (Off-campus)
Coordinator(s)Ms Adriana Tiziani

Notes

Quota applies

This unit is quota restricted. Selection is on a first-in, first enrolled basis. For more information please contact the faculty at http://www.monash.edu.au/pharm/future/contact/

Synopsis

This unit discusses the more common causes of cutaneous ulceration other than venous insufficiency i.e. skin cancer. The three main types of skin cancer are described, as are the principles of treatment and prognosis Other topics covered include clinical features and treatment of Eczema, Vasculitis, Necrobiosis lipoidica, Pyoderma gangrenosum, Mycobacterium Ulcerans and Chromoblastomyosis.

Outcomes

At the completion of this unit students will be able to:

  • Discuss the common causes of cutaneous ulcers.
  • Discuss the diagnosis and treatment of skin cancers.
  • Demonstrate an understanding of the diagnosis and management of dermatitis (eczema).
  • Demonstrate an understanding of the diagnosis and management of less common cause of cutaneous ulcers.

Assessment

Minor assignment: 30%
Major written assignment: 60% (hurdle)
Participation in online tutorials: 10%

Chief examiner(s)

Workload requirements

Students are expected to allow 3- 6 hours per week over the semester in study time.

This unit applies to the following area(s) of study

Prohibitions

PGW1109 (VCW1109)


3 points, SCA Band 2, 0.0625 EFTSL

Refer to the specific census and withdrawal dates for the semester(s) in which this unit is offered, or view unit timetables.

LevelPostgraduate
FacultyFaculty of Pharmacy and Pharmaceutical Sciences
OfferedNot offered in 2014
Coordinator(s)Ms Adriana Tiziani

Notes

Quota applies

This unit is quota restricted. Selection is on a first-in, first enrolled basis. For more information please contact the faculty at http://www.monash.edu.au/pharm/future/contact/

Synopsis

An increasing number of people are turning to alternative therapies to improve the condition of their health and quality of life. Although alternative therapists administer many of these therapies such as biomechanical devices, light therapy, laser treatment, electrical stimulation, hyperbaric treatment, systemic herbal treatment, an increasing number of healthcare professionals are compelled to administer/dispense these products. This unit will provide the participant with the necessary knowledge and skills to make sound clinical judgement regarding the use and benefit of alternative therapies in the healing process of wounds.

Outcomes

At the completion of this unit students will be able to:

  • Identify a number of alternative therapies in wound management.
  • Describe the mechanism of action for each modality.
  • Determine the plausibility of therapies with no proven mechanism of action.
  • Describe the level of evidence to support the use of each modality.
  • Describe wound types or conditions that may be suitable for various modalities.
  • Critically evaluate other modalities not described in this module based on the level of evidence and plausibility of the mechanism of action.

Assessment

Minor assignment: 30%
Major assignment: 60% (hurdle)
Participation in online tutorials: 10%

Chief examiner(s)

Workload requirements

Students are expected to allow 3- 6 hours per week over the semester in study time.

This unit applies to the following area(s) of study

Prohibitions

PGW1111 (VCW1111)


3 points, SCA Band 2, 0.0625 EFTSL

Refer to the specific census and withdrawal dates for the semester(s) in which this unit is offered, or view unit timetables.

LevelPostgraduate
FacultyFaculty of Pharmacy and Pharmaceutical Sciences
OfferedNot offered in 2014
Coordinator(s)Ms Adriana Tiziani

Notes

Quota applies

This unit is quota restricted. Selection is on a first-in, first enrolled basis. For more information please contact the faculty at http://www.monash.edu.au/pharm/future/contact/

Synopsis

The treatment of scars has become increasingly complex with a growing array of techniques and products available for use. The related costs for the management of scars is also expanding. This elective aims to explore current scar management practices and their evidential base. Knowledge of scar histology and appropriate outcome measurements will be used to critically evaluate interventions such as pressure therapy, massage and the use of contact media.

Outcomes

At the completion of this unit students will be able to:

  • Outline the process of scar formation and how it affects the function of normal skin.
  • Define the difference between normal scar and problematic scar.
  • Describe methods of scar assessment.
  • Critically evaluate the different types of management of scars: medical management, pressure therapy, massage, use of contact media.
  • Identify the psychosocial impact of a significant scar on the individuals quality of life.

Assessment

Minor assignment: 30%
Major assignment: 60% (hurdle)
Participation in online tutorials: 10%

Chief examiner(s)

Workload requirements

Students are expected to allow 3- 6 hours per week over the semester in study time.

This unit applies to the following area(s) of study

Prohibitions

PGW1112 (VCW1112)


6 points, SCA Band 2, 0.125 EFTSL

Refer to the specific census and withdrawal dates for the semester(s) in which this unit is offered, or view unit timetables.

LevelPostgraduate
FacultyFaculty of Pharmacy and Pharmaceutical Sciences
OfferedNot offered in 2014
Coordinator(s)Ms Adriana Tiziani

Notes

Quota applies

This unit is quota restricted. Selection is on a first-in, first enrolled basis. For more information please contact the faculty at http://www.monash.edu.au/pharm/future/contact/

Synopsis

This unit explores the complex issues and challenges associated with non-healing wounds. Students will gain an understanding of palliation, management of odour, exudate and pain management for people with fungating, cancerous wounds, radiation ulcers and non-healing chronic wounds.

Outcomes

At the completion of this unit students will be able to:

  • Demonstrate an understanding of the aetiology and physiology of non-healing wounds.
  • Identify the types of wounds that require palliative management.
  • Discuss the palliative care and challenges associated with the management of fungating wounds, cancerous wounds, radiation ulcers and non-healing chronic wounds.
  • Demonstrate an understanding of the pathophysiology of pain in palliative wound care.
  • Demonstrate and understanding of pain assessment techniques in palliative care.
  • Identify the treatment modalities for pain and critically appraise their effectiveness.

Assessment

Two minor assignments: 30%
One major assignment: 50% (hurdle)
Participation in online tutorials: 20%

Chief examiner(s)

Workload requirements

Students are expected to allow 10-12 hours per week over the semester in study time.

This unit applies to the following area(s) of study

Prohibitions

PGW1113 (VCW1113)


6 points, SCA Band 2, 0.125 EFTSL

Refer to the specific census and withdrawal dates for the semester(s) in which this unit is offered, or view unit timetables.

LevelPostgraduate
FacultyFaculty of Pharmacy and Pharmaceutical Sciences
OfferedParkville Second semester 2014 (Off-campus)
Coordinator(s)Ms Adriana Tiziani

Notes

Quota applies

This unit is quota restricted. Selection is on a first-in, first enrolled basis. For more information please contact the faculty at http://www.monash.edu.au/pharm/future/contact/

Synopsis

This unit deals with the assessment and management of clients with diabetic foot disease. We explore the aetiology and clinical presentation of complications of diabetes mellitus that manifest in the lower limb and foot. Assessment of diabetic foot disorders will focus on pressure and foot mechanics, peripheral sensation and circulation. Clinical management and evaluation of diabetic foot wounds will cover wound dressings, antibiotics, debridement and orthopaedic reconstruction, along with other health related issues.

Outcomes

At the completion of this unit students will be able to:

  • Review the anatomy and unique weight bearing functions of the foot.
  • Review the pathophysiology, general clinical presentation and medical management of diabetes mellitus.
  • Describe the aetiology, pathophysiology and clinical presentation of lower limb and foot complications in diabetes mellitus.
  • Discuss issues associated with weight bearing functions of the foot and the role of mechanical factors in diabetic foot ulceration.
  • Identify and discuss the causes of foot ulceration in diabetes demonstrating an appreciation for the multi-factorial nature of this complication.
  • Describe the process of clinical assessment of the foot in diabetes and the diabetic foot wound.
  • Identify and discuss what constitutes the 'high risk' foot in diabetes.
  • Detail the holistic management of diabetic foot wounds including local wound care, pressure reduction techniques, medical management, psychological/sociological aspects of the care plan and the role of the health care team.
  • Outline and describe the potential complications of diabetic foot wounds including infection and amputation.

Assessment

Two minor assignments: 30%
One major assignment: 50% (hurdle)
Participation in online tutorials: 20%

Chief examiner(s)

Workload requirements

Students are expected to allow 10-12 hours per week over the semester in study time.

This unit applies to the following area(s) of study

Prohibitions

PGW1116 (VCW1116)


6 points, SCA Band 2, 0.125 EFTSL

Refer to the specific census and withdrawal dates for the semester(s) in which this unit is offered, or view unit timetables.

LevelPostgraduate
FacultyFaculty of Pharmacy and Pharmaceutical Sciences
OfferedNot offered in 2014
Coordinator(s)Ms Adriana Tiziani

Notes

Quota applies

This unit is quota restricted. Selection is on a first-in, first enrolled basis. For more information please contact the faculty at http://www.monash.edu.au/pharm/future/contact/

Synopsis

This unit will explore issues surrounding the development of advanced practice in wound care including ethics, evidence based practice, critical thinking and critical reasoning, reflective practice, cost-effectiveness, client-centred practice and the development of expertise and leadership.

Outcomes

At the completion of this unit students will be able to:

  • Demonstrate an understanding of the role of the advanced wound practitioner.
  • Demonstrate the role of evidence based practice wound care in the management of complex wounds.
  • Identify and critically discuss issues surrounding effective planning, implementation and evaluation of interventions for a variety of complex wounds.
  • Critically discuss wound management interventions in light of current research.

Assessment

Clinical portfolio (the clinical portfolio will include 3 case studies focussing on the participant's evidence-based approach to clinical management of complex wounds): 50% (hurdle)
Wound care related teaching session: 10% (hurdle)
Reflective journal (participants will be required to maintain a reflective journal throughout the unit focussing on clinical and professional issues): 20% (hurdle)
Critical review of a wound care related journal article: 10% (hurdle)
Participation in online tutorial discussions: 10% (hurdle)

Chief examiner(s)

Workload requirements

Students are expected to allow 10-12 hours per week over the semester in study time.

This unit applies to the following area(s) of study

Prerequisites

PGC5001 (VCG5011), PGW5101 (PGW1101, VCW1101), PGW5102 (PGW1102, VCW1102), PGW5103 (PGW1103, VCW1103), PGW5104 (PGW1104, VCW1104), PGW5105 (PGW1105, VCW1105), PGW5106 (VCW1106), PGW5108 (VCW1108), PGW5127 (VCW1127)

Prohibitions

PGW6122 (VCW1122)


3 points, SCA Band 2, 0.0625 EFTSL

Refer to the specific census and withdrawal dates for the semester(s) in which this unit is offered, or view unit timetables.

LevelPostgraduate
FacultyFaculty of Pharmacy and Pharmaceutical Sciences
OfferedParkville Term 3 2014 (Off-campus)
Coordinator(s)Ms Adriana Tiziani

Notes

Quota applies

This unit is quota restricted. Selection is on a first-in, first enrolled basis. For more information please contact the faculty at http://www.monash.edu.au/pharm/future/contact/

Synopsis

Burns can present serious problems. Burn injuries can affect the nervous, respiratory and circulatory systems that impact on thermal regulation, muscle function and fluid balance. This module will cover the aetiology of burns including thermal, chemical, electrical and radiation burns; the classification of burns; the role and application of debriding, grafting and tissue engineering as strategies to effectively manage the different types of burns; factors that influence the strategies used to manage wounds such as the age of the victim, pre-existing conditions such as diabetes; and issues associated with scarring and contracture.

Outcomes

At the completion of this unit students will be able to:

  • Demonstrate an understanding of the mechanisms of injury and physiology of burns. + Explain immediate first aid and emergency management of a burns injury.
  • Describe the management of burns in terms of severity of burn, topical management, surgical management, pain control, nutritional support.
  • Identify and explain the potential complications associated with burn injury.
  • Demonstrate an understanding of the rehabilitation and long-term consequences of burn injury.

Assessment

Minor assignment: 30%
Major written assignment: 60% (hurdle)
Participation in online tutorials: 10%

Chief examiner(s)

Workload requirements

Students are expected to allow 3- 6 hours per week over the semester in study time.

This unit applies to the following area(s) of study

Prohibitions

PGW1123 (VCW1123)


6 points, SCA Band 2, 0.125 EFTSL

Refer to the specific census and withdrawal dates for the semester(s) in which this unit is offered, or view unit timetables.

LevelPostgraduate
FacultyFaculty of Pharmacy and Pharmaceutical Sciences
OfferedParkville First semester 2014 (Off-campus)
Parkville Second semester 2014 (Off-campus)
Coordinator(s)Ms Adriana Tiziani

Notes

Quota applies

This unit is quota restricted. Selection is on a first-in, first enrolled basis. For more information please contact the faculty at http://www.monash.edu.au/pharm/future/contact/

Synopsis

The clinical project in wound management consolidates the theoretical and practical skills acquired in the Graduate Diploma in Wound Care by exploring in detail a complex client issue within the candidate's workplace or a health care setting. The clinical project is not intended to be an original piece of research. Each student is expected to negotiate their topic in consultation with their lecturer.

Outcomes

At the completion of this subject the participant will be able to:

  • Develop a project proposal for a wound-related issue.
  • Write a project proposal and submit an ethics proposal.
  • Determine correct methodology and analysis for a project.
  • Present a project proposal to a panel.

Assessment

Written presentation of project proposal: 45% (hurdle)
Oral presentation of project proposal: 45% (hurdle)
Monash supervisor mark: 10%

Chief examiner(s)

This unit applies to the following area(s) of study

Prerequisites

PGC5001 (VCG5011), PGW5101 (PGW1101, VCW1101), PGW5102 (PGW1102, VCW1102), PGW5103 (PGW1103, VCW1103), PGW5104 (PGW1104, VCW1104), PGW5105 (PGW1105, VCW1105), PGW5106 (VCW1106), PGW5108 (VCW1108), PGW5127 (VCW1127)

Prohibitions

PGW6124 (VCW1124)


6 points, SCA Band 2, 0.125 EFTSL

Refer to the specific census and withdrawal dates for the semester(s) in which this unit is offered, or view unit timetables.

LevelPostgraduate
FacultyFaculty of Pharmacy and Pharmaceutical Sciences
OfferedParkville First semester 2014 (Off-campus)
Coordinator(s)Ms Adriana Tiziani

Notes

Quota applies

This unit is quota restricted. Selection is on a first-in, first enrolled basis. For more information please contact the faculty at http://www.monash.edu.au/pharm/future/contact/

Synopsis

This unit will provide students with a clinical risk management framework for managing and preventing wounds. This unit will explore the evidential basis for prevention strategies for wounds such as skin tears, leg ulcer and pressure ulcers. Students will not only explore client issues associated with prevention but also explore the local environment and organisational factors that influence prevention in both the hospital and community setting.

Outcomes

At the completion of this unit students will be able to:

  • Demonstrate an understanding of clinical risk management in relation to wound prevention.
  • Identify and discuss the incidence and prevalence of wounds in the hospital and community setting.
  • Discuss the prevention strategies and evidential basis supporting wound prevention.
  • Utilise a clinical risk management approach to manage skin tears, leg ulcers, diabetic foot ulcers, pressure ulcers.
  • Identify client, local and organisational barriers to wound prevention.
  • Determine appropriate measures for monitoring effectiveness of wound prevention strategies for the individual and the health care service.

Assessment

Two minor assignments: 30%
One major assignment: 50% (hurdle)
Participation in online tutorials: 20%

Chief examiner(s)

Workload requirements

Students are expected to allow 10-12 hours per week over the semester in study time.

This unit applies to the following area(s) of study

Prohibitions

PGW1126 (VCW1126)


6 points, SCA Band 2, 0.125 EFTSL

Refer to the specific census and withdrawal dates for the semester(s) in which this unit is offered, or view unit timetables.

LevelPostgraduate
FacultyFaculty of Pharmacy and Pharmaceutical Sciences
OfferedParkville Summer semester A 2014 (On-campus block of classes)
Parkville Winter semester 2014 (On-campus block of classes)
Coordinator(s)Ms Adriana Tiziani

Notes

For postgraduate coursework pharmacy discontinuation dates, please see http://www.pharm.monash.edu.au/students/pg-coursework/unit-discontinuation-dates.html

Quota applies

This unit is quota restricted. Selection is on a first-in, first enrolled basis. For more information please contact the faculty at http://www.monash.edu.au/pharm/future/contact/

Synopsis

This is a one week core unit conducted on-campus. This program includes clinical observation in Melbourne metropolitan wound clinics and a series of workshops on specific practical wound skills such as, measuring ABI using Doppler, debridement of wounds, compression bandaging, assessment of complex clients and dressing product selection. Please note that places in this unit are limited.

Outcomes

At the completion of this unit students will be able to:

  • Describe the attitudes and attributes required to work in a multidisciplinary clinical setting.
  • Demonstrate the relationship between the theoretical knowledge and the application of practical skills in a wound management environment.
  • Demonstrate skills in a range of management techniques required to diagnose and effectively manage a wound, such as: Doppler and Ankle-Brachial Index assessment, debridement, compression bandaging, selection of hosiery; assessment of complex clients; product selection.

Assessment

Reflective journal: 40% (The Reflective Journal is comprised of wound clinics observations: 20% and own practice experiences: 20%). (hurdle)
Client assessment case study (oral): 25% (hurdle)
Client assessment case study (written): 25% (hurdle)
Participant performance in class activities: 10% (hurdle)

Chief examiner(s)

Off-campus attendance requirements

One week conducted on-campus Parkville, in Winter semester (June) or Summer semester A (November).

This unit applies to the following area(s) of study

Prerequisites

PGW5101 (PGW1101, VCW1101), PGW5102 (PGW1102, VCW1102), PGW5103 (PGW1103, VCW1103), PGW5104 (PGW1104, VCW1104), PGW5105 (PGW1105, VCW1105)

Prohibitions

VCW1127


6 points, SCA Band 2, 0.125 EFTSL

Refer to the specific census and withdrawal dates for the semester(s) in which this unit is offered, or view unit timetables.

LevelPostgraduate
FacultyFaculty of Pharmacy and Pharmaceutical Sciences
OfferedParkville First semester 2014 (Off-campus)
Parkville Second semester 2014 (Off-campus)
Coordinator(s)Ms Adriana Tiziani

Notes

Quota applies

This unit is quota restricted. Selection is on a first-in, first enrolled basis. For more information please contact the faculty at http://www.monash.edu.au/pharm/future/contact/

Synopsis

This unit is a natural progression from Clinical project 1, which allows the student to further consolidate their research skills by completing the project developed in that unit. Emphasis will be on analysing the literature surrounding the topic, collecting and appropriately analysing the data, drawing conclusion from the project and development of a final project report.

Outcomes

At the completion of this unit the participant will be able to:

  • Demonstrate the ability to undertake critical analysis of a wound care related issue.
  • Critique a body of research related to wound care.
  • Explore the impact of wounds from an individual and population health perspective. + Identify driving forces and barriers to innovations in wound practices.
  • Utilise a systems approach to instigate change at an organisational and local level.

Assessment

Literature review: 30% (hurdle)
Progress report: 5% (hurdle)
Final report: 60% (hurdle)
Monash supervisor mark: 5%

Chief examiner(s)

Workload requirements

Students are expected to allow 3- 6 hours per week over the semester in study time.

This unit applies to the following area(s) of study

Prerequisites

PGW5124 (PGW6124, VCW1124)

Prohibitions

PGW6128 (VCW1128)


6 points, SCA Band 2, 0.125 EFTSL

Refer to the specific census and withdrawal dates for the semester(s) in which this unit is offered, or view unit timetables.

LevelPostgraduate
FacultyFaculty of Pharmacy and Pharmaceutical Sciences
OfferedParkville Second semester 2014 (Off-campus)
Coordinator(s)Ms Adriana Tiziani

Notes

Quota applies

This unit is quota restricted. Selection is on a first-in, first enrolled basis. For more information please contact the faculty at http://www.monash.edu.au/pharm/future/contact/

Synopsis

This Unit deals with the fundamental issues surrounding pressure ulcer prediction, prevention and management. An introduction into the impact that pressure ulcers have on the community will provide the basis for exploring the epidemiology, aetiology, causes and risk factors associated with the development of pressure ulcers. Skin assessment and pressure ulcer risk assessment tools will be investigated for their role in predicting and preventing pressure ulcer development. Management issues for pressure ulcers such as the selection and use of pressure redistributing devices will be explored, along with quality of life, legal and ethical issues.

Outcomes

At the completion of this unit the student will be able to:

  • Discuss the impact of pressure ulcer development on the community.
  • Discuss the aetiology, causes and factors which may lead to the development of pressure ulcers.
  • Describe the following: reactive hyperaemia, blanching erythema and non-blanching erythema.
  • Differentiate between the terms capillary pressure, capillary closing pressure and tissue interface pressure.
  • Distinguish between skin assessment and pressure ulcer risk assessment and discuss the importance of both.
  • Compare and contrast the Braden, Waterlow and Norton Scales for pressure ulcer risk assessment.
  • Discuss principles of pressure ulcer prevention.
  • Discuss principles of pressure ulcer management, including the use of pressure redistributing devices.
  • Identify quality of life issues for the person with the pressure ulcer.
  • Identify legal and ethical issue relating to pressure ulcers.

Assessment

Two minor assignments: 30%
One major assignment/Case Study Report: 50% (hurdle)
Participation in online tutorials: 20%

Chief examiner(s)

Workload requirements

Students are expected to allow 10-12 hours per week over the semester in study time.

This unit applies to the following area(s) of study

Prohibitions

PGW1130 (VCW1130)


0 points, SCA Band 2, 0.000 EFTSL

Refer to the specific census and withdrawal dates for the semester(s) in which this unit is offered, or view unit timetables.

LevelPostgraduate
FacultyFaculty of Pharmacy and Pharmaceutical Sciences
OfferedParkville Research quarter 1 2014 (Day)
Parkville Research quarter 2 2014 (Day)
Parkville Research quarter 3 2014 (Day)
Parkville Research quarter 4 2014 (Day)

Synopsis

Research in medicinal chemistry

This unit is used by the faculty and/or Monash Institute of Graduate Research to enrol students undertaking Higher Degrees by Research. Students will not be able to enrol in this unit via WES.


0 points, SCA Band 2, 0.000 EFTSL

Refer to the specific census and withdrawal dates for the semester(s) in which this unit is offered, or view unit timetables.

LevelPostgraduate
FacultyFaculty of Pharmacy and Pharmaceutical Sciences
OfferedParkville Research quarter 1 2014 (Day)
Parkville Research quarter 1 2014 (External Candidature)
Parkville Research quarter 2 2014 (Day)
Parkville Research quarter 2 2014 (External Candidature)
Parkville Research quarter 3 2014 (Day)
Parkville Research quarter 3 2014 (External Candidature)
Parkville Research quarter 4 2014 (Day)
Parkville Research quarter 4 2014 (External Candidature)

Synopsis

Research in pharmaceutical biology and pharmacology.

This unit is used by the faculty and/or Monash Institute of Graduate Research to enrol students undertaking Higher Degrees by Research. Students will not be able to enrol in this unit via WES.


0 points, SCA Band 2, 0.000 EFTSL

Refer to the specific census and withdrawal dates for the semester(s) in which this unit is offered, or view unit timetables.

LevelPostgraduate
FacultyFaculty of Pharmacy and Pharmaceutical Sciences
OfferedParkville Research quarter 1 2014 (Day)
Parkville Research quarter 2 2014 (Day)
Parkville Research quarter 3 2014 (Day)
Parkville Research quarter 4 2014 (Day)

Synopsis

Research in pharmaceutics.

This unit is used by the faculty and/or Monash Institute of Graduate Research to enrol students undertaking Higher Degrees by Research. Students will not be able to enrol in this unit via WES.


0 points, SCA Band 2, 0.000 EFTSL

Refer to the specific census and withdrawal dates for the semester(s) in which this unit is offered, or view unit timetables.

LevelPostgraduate
FacultyFaculty of Pharmacy and Pharmaceutical Sciences
OfferedParkville Research quarter 1 2014 (Day)
Parkville Research quarter 1 2014 (External Candidature)
Parkville Research quarter 2 2014 (Day)
Parkville Research quarter 2 2014 (External Candidature)
Parkville Research quarter 3 2014 (Day)
Parkville Research quarter 3 2014 (External Candidature)
Parkville Research quarter 4 2014 (Day)
Parkville Research quarter 4 2014 (External Candidature)

Synopsis

Research in pharmacy practice.

This unit is used by the faculty and/or Monash Institute of Graduate Research to enrol students undertaking Higher Degrees by Research. Students will not be able to enrol in this unit via WES.


0 points, SCA Band 2, 0.000 EFTSL

Refer to the specific census and withdrawal dates for the semester(s) in which this unit is offered, or view unit timetables.

LevelPostgraduate
FacultyFaculty of Pharmacy and Pharmaceutical Sciences
OfferedParkville Research quarter 1 2014 (Day)
Parkville Research quarter 1 2014 (External Candidature)
Parkville Research quarter 2 2014 (Day)
Parkville Research quarter 2 2014 (External Candidature)
Parkville Research quarter 3 2014 (Day)
Parkville Research quarter 3 2014 (External Candidature)
Parkville Research quarter 4 2014 (Day)
Parkville Research quarter 4 2014 (External Candidature)

Synopsis

Research in drug discovery biology.
This unit is used by the faculty and /or Monash Institute of Graduate Research to enrol students undertaking Higher Degrees by Research. Students will not be able to enrol in this unit via WES.